- •
The Vibrant Soundbridge is a semi-implantable, active middle ear implant.
- •
This device is an effective and safe alternative for the treatment of sensorineural hearing loss.
- •
It is used internationally for the treatment of conductive and mixed hearing losses of all types.
- •
It is currently under investigation for conductive and mixed loss in the United States.
The Vibrant Soundbridge: A Global Overview
Section snippets
Key points
Implant description
This semi-implantable device (Fig. 1) consists of an externally worn audio processor (AP) and the implanted vibrating ossicular replacement prosthesis (VORP) that consists of the floating mass transducer (FMT) and a receiver stimulator (RS) that are connected via a conductor link. The FMT (Fig. 2) weighs 25 mg and consists of an electromagnetic coil that surrounds a small magnet.
Similar to a cochlear implant, the AP receives the acoustic signal and modulates and converts it to an electric
Vibrant Soundbridge advantages in sensorineural hearing loss
- •
Natural sound quality
- •
Open ear canal
- •
No feedback, distortion, occlusion
- •
Improved speech discrimination in noise
- •
Improved aesthetics over visible hearing aids
Patient criteria for sensorineural hearing loss
- •
Stable moderate to severe SNHL (Fig. 3)
- •
No middle ear disease, normal immittance
- •
Speech discrimination >50%
- •
Healthy scalp at AP site
Indications for sensorineural hearing loss
- •
Ear canal problems
- •
Side effects from hearing aid use
- •
Dissatisfaction with hearing aid sound quality/cosmesis
Surgery for sensorineural hearing loss
The RS is implanted as in cochlear implant surgery (Fig. 4). In the United States (VORP 502; Fig. 5A), the opening of the facial recess must be generous to allow for crimping of the clip of the FMT to the incus long process (Fig. 6). In 2014, the VORP 503 (Fig. 5B) was released in international markets. It features a thinner implant design, fixation wings for self-drilling screws, and a shorter and more robust conductor link. The FMT is without a titanium clip and is placed with one of several
Patient criteria for conductive hearing loss and mixed hearing loss
- •
Stable bone conduction thresholds (Fig. 9)
- •
Speech discrimination greater than 50%
- •
Medically unable to wear acoustic hearing aid
- •
Inadequate benefit/functional gain from hearing aid
Surgery for conductive hearing loss and mixed hearing loss
Hearing results in chronic ear surgery often remain unsatisfactory, and amplification with acoustic hearing aids can be insufficient or cause infection. Percutaneous osseointegrated bone-anchored hearing aids, although surgically simple, are frequently rejected by patients, require significant care, and are associated with long-term complications. Expansion of the VSB indications was therefore desirable. Vibrometer studies had demonstrated similar cochlear fluid movement with vibration of the
Summary
The VSB is a versatile device for the treatment of SNHL, CHL, and MHL in patients with normal and abnormal anatomy. In the United States, it is FDA approved for SNHL in patients 18 years and older and has been found to be a safe and effective alternative to traditional hearing aids. Longitudinal studies show safety and device stability. There is a great international body of research with expansion of indications. It is C-marked for SNHL, CHL, and mixed hearing loss down to age 3 in Europe.
References (43)
- et al.
clinical trial results with the Vibrant Soundbridge implantable middle ear hearing device: a prospective controlled multicenter study
Otolaryngol Head Neck Surg
(2002) - et al.
Round window membrane motion with air conduction and bone conduction stimulation
Hear Res
(2004) - et al.
Surgical approaches to position the Vibrant Soundbridge in conductive and mixed hearing loss
Operative Techniques in Otolaryngology-Head
(2010) - et al.
Clinical experience with the Vibrant Soundbridge implant device
Otol Neurotol
(2001) - et al.
Multicenter audiometric results with the Vibrant Soundbridge, a semi-implantable hearing device for sensorineural hearing impairment
Otolaryngol Clin North Am
(2001) - et al.
Factors improving the vibration transfer of the floating mass transducer at the round window
Otol Neurotol
(2010) - et al.
Retrospective of 1000 patients implanted with a vibrant Soundbridge middle-ear implant
Cochlear Implants Int
(2005) - et al.
A middle ear implant, the Symphonix Vibrant Soundbridge: retrospective study of the first 125 patients implanted in France
Otol Neurotol
(2003) - et al.
A multicenter study of the Vibrant Soundbridge middle ear implant: early clinical results and experience
Otol Neurotol
(2001) - et al.
A longitudinal study on postoperative hearing thresholds with the Vibrant Soundbridge device
Eur Arch Otorhinolaryngol
(2004)
Long-term assessment after implantation of the Vibrant Soundbridge device
Otol Neurotol
Vibrant Soundbridge implantable hearing device: critical review and single-surgeon short- and long-term results
Ear Nose throat J
Active middle ear implantation: long-term medical and technical and complications
Otol Neurotol
Benefit of the Vibrant Soundbridge device in patients implanted for 5 to 8 years
Ear Hear
Direct round window stimulation with the Med-El Vibrant Soundbridge: 5 years of experience using a technique without interposed fascia
Eur Arch Otorhinolaryngol
Vibrant Sound Bridge System. A new kind hearing prosthesis for patients with sensorineural hearing loss 2 Audiological results
Laryngorhinootologie
Scanning laser Doppler vibrometry of the middle ear ossicles
Ear Nose Throat J
Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window
Int J Audiol
TORP vs round window implant for hearing restoration of patients with extensive ossicular chain defect
Acta Otolaryngol
van Active middle ear implants in patients undergoing subtotal petrosectomy: new application for the Vibrant Soundbridge device and its implication for lateral cranium base surgery
Otol Neurotol
The vibrant soundbridge for conductive and mixed hearing losses: European multicenter study results
Adv Otorhinolaryngol
Cited by (16)
Brazilian Society of Otology task force – Otosclerosis: evaluation and treatment
2023, Brazilian Journal of OtorhinolaryngologyEffect of magnet position in an electromagnetic transducer for the middle ear implant
2023, Journal of Sound and VibrationStapes vibrations induced by piezoelectric floating mass transducer
2023, Journal of Sound and VibrationTask force Guideline of Brazilian Society of Otology – hearing loss in children – Part II — Treatment
2023, Brazilian Journal of OtorhinolaryngologyCitation Excerpt :Initially, the FMT was coupled only to the long process of the incus. Currently, new couplers allow the FMT to be placed on the short process of the incus, stapes superstructure, and round window.96 VSB model 503 supports up to 1.5 Tesla MRI,97 whereas earlier models are incompatible with MRI.
Effect of linear electromechanical coupling in nonlinear implanted human middle ear
2021, Mechanical Systems and Signal ProcessingCitation Excerpt :IMEHDs can be used for both conductive and sensorineural hearing loss, therefore they are becoming more and more popular nowadays. A typical IMEHD consists of three parts: a microphone, a signal processor and a vibrating output transducer known as a floating mass transducer (FMT))[20,2,3]. The literature of the subject usually reports clinical studies on the application of IMEHDs in various medical cases [19,22,42,8,16,38,28].
Disclosure Statement: None.